Increased expression of hepatocyte growth factor (HGF) and its receptor (c-MET) in malignants insulinomas (2006)
- Authors:
- USP affiliated authors: GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; PATZINA, ROSELY ANTUNES - FM ; MACHADO, MARCEL CERQUEIRA CESAR - FM
- Unidade: FM
- Subjects: NEOPLASIAS; FATORES DE CRESCIMENTO; HEPATOPATIAS; INSULINA; RESUMOS (CONGRESSOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Resumos
- Conference titles: ENDO 06 - Annual Meeting the endocrine society's
-
ABNT
SA, Sandra V. et al. Increased expression of hepatocyte growth factor (HGF) and its receptor (c-MET) in malignants insulinomas. 2006, Anais.. Boston: Faculdade de Medicina, Universidade de São Paulo, 2006. . Acesso em: 28 dez. 2025. -
APA
Sa, S. V., Rosa, P. W. L., Giannella, M. L. C. C., Pereira, M. A. A., Patzina, R. A., Siqueira, S. A. C., & Machado, M. C. C. (2006). Increased expression of hepatocyte growth factor (HGF) and its receptor (c-MET) in malignants insulinomas. In Resumos. Boston: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Sa SV, Rosa PWL, Giannella MLCC, Pereira MAA, Patzina RA, Siqueira SAC, Machado MCC. Increased expression of hepatocyte growth factor (HGF) and its receptor (c-MET) in malignants insulinomas. Resumos. 2006 ;[citado 2025 dez. 28 ] -
Vancouver
Sa SV, Rosa PWL, Giannella MLCC, Pereira MAA, Patzina RA, Siqueira SAC, Machado MCC. Increased expression of hepatocyte growth factor (HGF) and its receptor (c-MET) in malignants insulinomas. Resumos. 2006 ;[citado 2025 dez. 28 ] - Expression Analysis of Hepatocyte Growth Factor (HGF) and Its Receptor (c-Met) in Insulinomas
- Expression profile of genes belonging to Trypsin/Chymotrysin and serine-type endopeptidase inhibitor activity pathways in insulinonas
- Hypertonic saline solution inhibits systemic inflammatory response but not local lesions in experimental acute pancreatitis
- Serpin Peptidase Inhibitor Clade A Member 1 as a Potential Marker for malignancy in Insulinomas
- Serpina 1 (alpha-1-antitrypsin) as a potential marker for malignancy of insulinomas
- Endogenous hyperinsulinemic hypoglycemia: Diagnostic strategies, predictive features of malignancy and long-term survival
- Expressão dos receptores de somatostatina (SSTR1 a 5 ) em tumores da célula beta
- Correlation of somatostatin receptor (SSTR) 3 and 5 expressions with tumor volume in insulinomas
- Expression of somatostatin receptors subtypes (SSTR1-5) in insolinomas
- Expression of serine-type endopeptidase pathway genes in insulinomas of benign and malignant behavior
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
